MedAssets Company Profile (NASDAQ:MDAS)

About MedAssets (NASDAQ:MDAS)

MedAssets logoMedAssets, Inc. (MedAssets) provides technology-enabled products and services to healthcare organizations, including hospitals, health systems, non-acute healthcare providers, payers, other service providers and product manufacturers. The Company operates its business through two business segments: Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM). The SCM segment delivers market insight, performance improvement advisory and cost management capabilities to healthcare providers. The RCM segment provides revenue cycle management solutions to healthcare providers, primarily hospitals and health systems. The Company's technology-enabled solutions are delivered through the Company-hosted software or software as a service (SaaS) or Web-based applications. Its Web-based applications employ cloud computing by using the Internet to deploy the Company's solutions across decentralized health care organizations, providing standardization and compliance.

Industry, Sector and Symbol:
  • Sector: Technology
  • Industry: IT Services & Consulting
  • Sub-Industry: Health Care Technology
  • Symbol: NASDAQ:MDAS
  • CUSIP: 58404510
  • Web: www.medassets.com
Average Prices:
  • 50 Day Moving Avg: $30.97
  • 200 Day Moving Avg: $25.46
  • 52 Week Range: $17.00 - $31.35
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 22.55
  • P/E Growth: 0.00
Profitability:
  • Net Margins: -1.18%
  • Return on Equity: -2.00%
  • Return on Assets: -0.54%
Misc:
  • Average Volume: 1.06 million shs.
 

Frequently Asked Questions for MedAssets (NASDAQ:MDAS)

What is MedAssets' stock symbol?

MedAssets trades on the NASDAQ under the ticker symbol "MDAS."

How were MedAssets' earnings last quarter?

MedAssets, Inc. (NASDAQ:MDAS) issued its earnings results on Wednesday, July, 29th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.27 by $0.04. The business earned $190.40 million during the quarter, compared to analysts' expectations of $187.45 million. MedAssets had a negative return on equity of 2.00% and a negative net margin of 1.18%. MedAssets's quarterly revenue was up 8.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.30 EPS. View MedAssets' Earnings History.

Who are some of MedAssets' key competitors?

How do I buy MedAssets stock?

Shares of MedAssets can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MedAssets' stock price today?

One share of MedAssets stock can currently be purchased for approximately $31.35.


MarketBeat Community Rating for MedAssets (NASDAQ MDAS)
Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  191 (Vote Outperform)
Underperform Votes:  280 (Vote Underperform)
Total Votes:  471
MarketBeat's community ratings are surveys of what our community members think about MedAssets and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for MedAssets (NASDAQ:MDAS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for MedAssets (NASDAQ:MDAS)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
1/27/2016William BlairReiterated RatingMarket PerformN/AView Rating Details
1/25/2016Canaccord GenuityReiterated RatingHoldN/AView Rating Details
11/20/2015Leerink SwannReiterated RatingHold$22.00 -> $31.35N/AView Rating Details
11/17/2015J P Morgan Chase & CoInitiated CoverageNeutral$19.00 -> $31.00N/AView Rating Details
11/3/2015SunTrust Banks, Inc.DowngradeBuy -> NeutralN/AView Rating Details
11/3/2015Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
11/3/2015Jefferies Group LLCDowngradeBuy -> Hold$25.00 -> $31.35N/AView Rating Details
11/3/2015FBR & CoBoost Price TargetMarket Perform$20.00 -> $31.00N/AView Rating Details
11/2/2015Piper Jaffray CompaniesUpgradeUnderweight -> NeutralN/AView Rating Details
10/21/2015Avondale PartnersInitiated CoverageOutperform$27.50N/AView Rating Details
10/1/2015Deutsche Bank AGReiterated RatingHold$22.00 -> $23.00N/AView Rating Details
10/1/2015Topeka Capital MarketsLower Price TargetHold$23.00 -> $22.00N/AView Rating Details
(Data available from 9/20/2015 forward)

Earnings

Earnings History for MedAssets (NASDAQ:MDAS)
Earnings by Quarter for MedAssets (NASDAQ:MDAS)
Earnings History by Quarter for MedAssets (NASDAQ MDAS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2015Q315$0.28$0.27$187.34 million$117.20 millionViewN/AView Earnings Details
7/29/2015Q2$0.27$0.31$187.45 million$190.40 millionViewListenView Earnings Details
4/29/2015Q115$0.30$0.31$184.33 million$185.58 millionViewN/AView Earnings Details
2/17/2015Q414$0.39$0.39$195.00 million$198.20 millionViewN/AView Earnings Details
10/29/2014Q314$0.31$0.34$172.50 million$175.70 millionViewListenView Earnings Details
7/30/2014Q214$0.29$0.30$175.70 million$175.42 millionViewListenView Earnings Details
4/30/2014Q114$0.29$0.27$172.30 million$170.87 millionViewListenView Earnings Details
2/26/2014Q413$0.28$0.30$165.64 million$170.50 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.26$0.30$167.64 million$170.70 millionViewN/AView Earnings Details
5/1/2013Q1 2013$0.30$0.41$164.75 million$172.84 millionViewN/AView Earnings Details
2/20/2013Q4 2012$0.28$0.27$159.84 million$163.80 millionViewN/AView Earnings Details
10/30/2012$0.26$0.32ViewN/AView Earnings Details
8/1/2012$0.22$0.28ViewN/AView Earnings Details
5/2/2012$0.18$0.24ViewN/AView Earnings Details
2/23/2012$0.32$0.32ViewN/AView Earnings Details
11/3/2011$0.16$0.26ViewN/AView Earnings Details
8/1/2011$0.16$0.23ViewN/AView Earnings Details
5/5/2011$0.16$0.17ViewN/AView Earnings Details
2/24/2011$0.22$0.18ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for MedAssets (NASDAQ:MDAS)
Current Year EPS Consensus Estimate: $1.30 EPS
Next Year EPS Consensus Estimate: $1.39 EPS

Dividends

Dividend History for MedAssets (NASDAQ:MDAS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for MedAssets (NASDAQ:MDAS)
Insider Trades by Quarter for MedAssets (NASDAQ:MDAS)
Institutional Ownership by Quarter for MedAssets (NASDAQ:MDAS)
Insider Trades by Quarter for MedAssets (NASDAQ:MDAS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/26/2015John A BardisDirectorSell2,000$19.73$39,460.00View SEC Filing  
2/24/2015John A BardisDirectorSell100,000$19.45$1,945,000.00View SEC Filing  
2/19/2015R Halsey WiseCEOBuy110,300$18.15$2,001,945.00View SEC Filing  
11/26/2014Keith L ThurgoodInsiderSell5,681$19.54$111,006.74View SEC Filing  
11/12/2014Harris Iv HymanDirectorSell3,334$20.50$68,347.00View SEC Filing  
11/11/2014John A BardisCEOSell100,000$20.02$2,002,000.00View SEC Filing  
11/7/2014John A BardisCEOSell191,833$20.74$3,978,616.42View SEC Filing  
11/4/2014John A BardisCEOSell208,167$21.48$4,471,427.16View SEC Filing  
10/28/2014Jonathan H GlennInsiderSell7,300$22.62$165,126.00View SEC Filing  
10/27/2014Jonathan H GlennInsiderSell500$22.50$11,250.00View SEC Filing  
8/13/2014Terrence J MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  
7/10/2014Terrence J MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  
7/1/2014Charles O GarnerCFOSell3,167$22.81$72,239.27View SEC Filing  
6/12/2014Terrence J MulliganDirectorSell1,000$23.30$23,300.00View SEC Filing  
5/14/2014Terrence MulliganDirectorSell1,000$22.93$22,930.00View SEC Filing  
5/2/2014R Halsey WiseDirectorBuy8,950$22.31$199,674.50View SEC Filing  
4/10/2014Terrence MulliganDirectorSell1,000$24.56$24,560.00View SEC Filing  
3/13/2014Terrence MulliganDirectorSell1,000$25.24$25,240.00View SEC Filing  
2/28/2014Charles GarnerCFOSell8,949$24.05$215,223.45View SEC Filing  
2/24/2014Terrence MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  
1/16/2014Charles GarnerCFOSell15,207$20.83$316,761.81View SEC Filing  
1/16/2014Terrence MulliganDirectorSell2,000$21.97$43,940.00View SEC Filing  
11/26/2013John RutherfordDirectorSell13,000$21.41$278,330.00View SEC Filing  
11/21/2013Bruce WessonDirectorSell60,263$20.54$1,237,802.02View SEC Filing  
11/15/2013Terrence MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  
11/8/2013John BardisCEOSell200,000$22.04$4,408,000.00View SEC Filing  
10/22/2013Lance M CulbrethCAOSell2,000$26.45$52,900.00View SEC Filing  
10/8/2013Terrence MulliganDirectorSell1,000$24.64$24,640.00View SEC Filing  
9/17/2013Terrence MulliganDirectorSell1,000$24.21$24,210.00View SEC Filing  
9/11/2013Lance M CulbrethCAOSell4,000$24.23$96,920.00View SEC Filing  
9/10/2013Jonathan H GlennInsiderSell12,268$24.00$294,432.00View SEC Filing  
8/29/2013Charles GarnerCFOSell2,017$23.02$46,431.34View SEC Filing  
8/29/2013Harris Iv HymanDirectorSell3,199$23.26$74,408.74View SEC Filing  
8/26/2013Harris Iv HymanDirectorSell5,985$23.50$140,647.50View SEC Filing  
8/23/2013C PiccoloDirectorSell17,487$22.94$401,151.78View SEC Filing  
8/23/2013John BardisCEOSell17,304$23.04$398,684.16View SEC Filing  
8/15/2013John BardisCEOSell10,000$22.87$228,700.00View SEC Filing  
8/14/2013Terrence MulliganDirectorSell5,000$23.50$117,500.00View SEC Filing  
8/9/2013John RutherfordDirectorSell50,000$23.62$1,181,000.00View SEC Filing  
8/5/2013Lance M CulbrethCAOSell22,866$23.34$533,692.44View SEC Filing  
8/2/2013Gregory StrobelInsiderSell4,025$22.78$91,689.50View SEC Filing  
8/2/2013Terrence MulliganDirectorSell29,446$23.39$688,741.94View SEC Filing  
7/23/2013Michael Patrick NolteCOOSell20,000$21.04$420,800.00View SEC Filing  
7/17/2013Lance M CulbrethCAOSell4,500$20.45$92,025.00View SEC Filing  
7/16/2013Michael Patrick NolteCOOSell19,222$19.63$377,327.86View SEC Filing  
7/16/2013Rand A BallardInsiderSell13,163$20.00$263,260.00View SEC Filing  
7/16/2013Terrence J MulliganDirectorSell55,000$20.00$1,100,000.00View SEC Filing  
5/10/2013Lance M CulbrethCAOSell16,000$18.54$296,640.00View SEC Filing  
3/25/2013Charles O GarnerCFOSell15,038$19.38$291,436.44View SEC Filing  
11/27/2012Gregory A StrobelInsiderSell10,000$16.24$162,400.00View SEC Filing  
11/27/2012John A BardisCEOSell107,550$16.51$1,775,650.50View SEC Filing  
11/14/2012John A BardisCEOSell71,340$16.34$1,165,695.60View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for MedAssets (NASDAQ:MDAS)
Latest Headlines for MedAssets (NASDAQ:MDAS)
Source:
DateHeadline
americanbankingnews.com logoBarracuda Networks (CUDA) vs. MedAssets (NASDAQ:MDAS) Critical Comparison
www.americanbankingnews.com - August 10 at 8:07 AM
americanbankingnews.com logoComputer Programs and Systems (CPSI) vs. MedAssets (MDAS) Head to Head Contrast
www.americanbankingnews.com - June 20 at 8:45 PM
finance.yahoo.com logoSmall-Caps: Hedge Fund Favorites
finance.yahoo.com - March 11 at 4:30 PM
finance.yahoo.com logoJunk Bond Issuance Gained Traction: 5 Key Deals
finance.yahoo.com - February 10 at 12:26 PM
finance.yahoo.com logoLeveraged Loan Funds Continued to Witness Outflows Last Week
finance.yahoo.com - February 4 at 12:07 AM
finance.yahoo.com logoLeveraged Loans Issuance Fell Last Week
finance.yahoo.com - January 30 at 9:07 PM
finance.yahoo.com logoMedAssets Named Category Leader in “2015/2016 Best in KLAS” Report
finance.yahoo.com - January 29 at 8:30 AM
moodys.com logoVizient, Inc. -- Moody's assigns B2 CFR to Vizient, Inc.; stable outlook
www.moodys.com - January 28 at 1:34 PM
thestreet.com logoNew Lifetime High Reached By MedAssets (MDAS)
www.thestreet.com - January 27 at 6:12 PM
biz.yahoo.com logoMEDASSETS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Ag
biz.yahoo.com - January 27 at 3:22 PM
globenewswire.com logoPamplona Capital Management Completes Acquisition of MedAssets for $2.75 Billion - GlobeNewswire (press release)
www.globenewswire.com - January 27 at 10:55 AM
finance.yahoo.com logoPamplona Capital Management Completes Acquisition of MedAssets for $2.75 Billion
finance.yahoo.com - January 27 at 10:30 AM
uk.finance.yahoo.com logoPamplona Capital Management Completes Acquisition of MedAssets
uk.finance.yahoo.com - January 27 at 10:30 AM
finance.yahoo.com logoMedAssets' Shareholders Approve Takeover by Pamplona
finance.yahoo.com - January 15 at 2:50 PM
biz.yahoo.com logoMEDASSETS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statem
biz.yahoo.com - January 14 at 4:13 PM
moodys.com logoMedAssets, Inc. (New). -- Moody's assigns B3 CFR to MedAssets, Inc. (New); rates LBO financing
www.moodys.com - January 6 at 3:30 PM
finance.yahoo.com logoTwo Chinese citizens in insider trading settlement with U.S. regulator
finance.yahoo.com - December 28 at 5:28 PM

Social

Chart

MedAssets (MDAS) Chart for Wednesday, September, 20, 2017

This page was last updated on 9/20/2017 by MarketBeat.com Staff